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Abstract
Identifying health status and disparities for Indigenous populations is the first logical step toward 
better health. We compare the mortality profile of the American Indian and Alaska Native (AI/AN) 
population with that of non-Hispanic whites in the Haudenosaunee Nations in New York State, the 
Indian Health Service (IHS) East region (Nashville Area) and the United States. Data from the 
linkage of IHS registration records with decedents from the National Death Index (1990–2009) 
were used to identify AI/AN deaths misclassified as non-AI/AN. Analyses were limited to persons 
of non-Hispanic origin. We analyzed trends for 1990–2009 and compared AI/AN and white 
persons in the Haudenosaunee Nations in New York State, IHS East region and the United States. 
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All-cause death rates over the past two decades for Haudenosaunee men declined at a greater 
percentage per year than for AI/AN men in the East region and United States. This decrease was 
not observed for Haudenosaunee women with all-cause death rates appearing to be stable over the 
past two decades. Haudenosaunee all-cause death rates were 16% greater than that for whites in 
the Haudenosaunee Nations. The most prominent disparities between Haudenosaunee and whites 
are concentrated in the 25–44 year age group (Risk Ratio=1.85). Chronic liver disease, diabetes, 
unintentional injury, and kidney disease death rates were higher in Haudenosaunee than in whites 
in the Haudenosaunee Nations. The Haudenosaunee cancer death rate (180.8 per 100,000) was 
higher than that reported for AI/AN in the East (161.5 per 100,000).Haudenosaunee experienced 
higher rates for the majority of the leading causes of death than East AI/AN. These results 
highlight the importance of Haudenosaunee-specific data to target prevention efforts to address 
health disparities and inequalities in health.
Keywords
cancer; diabetes; health disparities; obesity; Native American; American Indian; Haudenosaunee; 
Iroquois; New York; minority health
BACKGROUND
Health disparities are health differences that are closely linked with social, economic, or 
environmentally disadvantaged communities or populations (U.S. Department of Health and 
Human Services, 2008). Health disparities adversely affect groups of people who have 
systematically experienced greater obstacles to health based on characteristics historically 
linked to discrimination or exclusion. Health disparities are measured by tracking rates of 
illness, death, chronic conditions, and behaviors related to socio-demographic features such 
as race and ethnicity (U.S. Department of Health and Human Services, 2008) –as well as 
income and education.
American Indians and Alaska Natives (AI/ANs)—Native Americans—experience excesses 
of a number of diseases that may be linked to environmental obstacles, health behaviors, or 
lifestyles attributed to the possible epigenetic factors of trauma or stress (Brown et al., 2010; 
Shonkoff, Boyce, & McEwen, 2009; Cobb, Espey, & King, 2014; Warne, 2006). The most 
common causes of death for AI/AN populations are heart disease, cancer, unintentional 
injuries, diabetes, stroke, chronic liver disease and cirrhosis, chronic lower respiratory 
disease, suicide, influenza, pneumonia, and kidney diseases. Health disparities in Indian 
Country (Natural Resources Conservation Science, n.d.) vary regionally and correspond to 
similar trends in mortality rates (Espey et al., 2014a; White et al., 2014; Li et al., 2014; 
Murphy et al., 2014; Indian Health Services, 2016). Obesity is likely a contributing factor to 
many of these diseases with AI/AN men and women having a higher prevalence of obesity 
than their white counterparts (Cobb et al., 2014; Moore, Chadid, Singer, Kreger, & Denis, 
2014; Haring et al. 2016).
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Cancer Health Disparities
Kilbourne and colleagues define health disparities for public health as the “observed 
clinically and statistically significant differences in health outcomes or health care use 
between socially distinct vulnerable and less vulnerable populations that are not explained 
by the effects of selection bias,” (Kilbourne, Switzer, Hyman, Crowley-Matoka, & Fine, 
2006). The National Cancer Institute (NCI) has further defined cancer-related health 
disparities as “adverse differences in new and existing cancer incidence (new cases), 
morbidity (cancer related health complications), cancer mortalities (death), cancer 
survivorship and burden of cancer or related health conditions that exist among specific 
population groups in the United States” (NCI, n.d.).
Cancer is the second leading cause of death in New York State (NYS). In 2009, the age-
adjusted cancer incidence rate for all cancers was 484.2 cases per 100,000 New Yorkers, 
which is the ninth highest in the United States (U.S.). The NYS age-adjusted mortality rate 
for all cancer sites is 164.3 per 100,000 population, which is almost 6% lower than the U.S. 
rate (173.8); the state’s overall cancer mortality rate decreased by an average of 2% each 
year across all ages and races between 2005–2009. Notably for this report, only cancers of 
the uterus and liver/bile duct had increases in annual mortality rates when looking at 5-year 
rate changes (NYS Cancer Consortium, 2012).
Incidence and mortality rates in NYS by race/ethnicity are reported highest among black 
men (NYS Cancer Consortium, 2012); however, incidence and mortality rates for AI/AN 
populations in NYS are not available for comparison from the State Cancer Profiles on 
Cancer Control P.L.A.N.E.T. (https://ccplanet.cancer.gov/) or the latest NYS Comprehensive 
Cancer Control Plan, possibly due to the challenges of reporting smaller case counts from 
identifiable areas and possible data-reporting errors. However, the 2012–2017 NYS 
Comprehensive Cancer Control Plan text states that AI/AN populations were one of several 
populations identified by New York’s Medicaid Redesign Team Health Disparities 
Workgroup “that may experience greater health disparities,” (NYS Cancer Consortium, 
2012). This team further states that “AI/AN groups face greater socioeconomic barriers than 
many other racial/ethnic groups” and “…should receive priority consideration when 
intervention strategies are being developed and implemented” (NYS Cancer Consortium, 
2012).
Haudenosaunee & Indian Health Service East Region
To address race misclassification in death records and cancer surveillance data, efforts have 
been made to better characterize and track the health status of AI/AN populations (Espey et 
al., 2014b; Espey et al., 2008). Mortality data provide essential information for measuring 
the health of a population. AI/AN mortality data are often presented for 12 Indian Health 
Service (IHS) Areas (Indian Health Service, n.d.) and six IHS regions (Northern Plains, 
Alaska, Southern Plains, Southwest, Pacific Coast, and East) (Espey et al., 2014b; Espey et 
al., 2008; Espey et al., 2007). Our interest lies in the IHS East region, which contains the 
same states as those in the IHS Nashville Area. This catchment includes a mixture of tribes 
with varying degrees of “first contact” with Europeans; varying levels of Nation-to-Nation 
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relationships with the United States; differences in culture, customs, and language; and vast 
geographic distances between states from the Northeast to the Southeast.
Previous studies have worked with individual Northeast Native Nations to look at tribal data 
on matrilineal enrolled members only (Mahoney, Va, Stevens, Kahn, & Michalek, 2009). 
Others have used Nation-specific health center data for review (Schulz, Lalicata, Carnes, & 
Rith-Najarian, 1997) or obtained data from school systems for community health 
information (Botash, Kavey, Emm, & Jones, 1992). Specific tribal data are useful for each 
Nation individually and helpful when looking at enrolled citizens, non-enrolled membership 
populations, or school-aged children. There is also a need to look at population health from 
both enrolled and non-enrolled tribal members to paint an inclusive picture of global tribal 
wellness and its relation to disparities. Therefore, the IHS East region lacks an aggregated 
picture of health disparities from the largest Confederacy of Tribes in NYS, whose 
bloodlines are distinctly related through clan systems, language, and traditional practices. 
The Haudenosaunee have land throughout a majority of NYS (Figure 1). The 
Haudenosaunee Confederacy tribes include the Mohawk, Oneida, Onondaga, Tuscarora, 
Cayuga, and Seneca. The Mohawk are known as the “Keepers of the Eastern Door” and are 
responsible for protecting and defending the eastern boundaries of Haudenosaunee territory 
(Smithsonian NMAI, n.d.). The Onondaga are the “Keepers of the Central Fire” since the 
Onondaga Nation is considered the capital of the Confederacy (Smithsonian NMAI, n.d.). 
The Seneca are the “Keepers of the Western Door” and are responsible for protecting and 
defending the western boundaries of Haudenosaunee territory (Smithsonian NMAI, n.d.).
In this article, we provide an overview of leading causes of death and all-cause mortality 
trends for AI/ANs and whites in the Haudenosaunee Nations, the East region, and the United 
States. We utilize national mortality data that have been linked to the IHS patient registration 
data to improve race/ethnicity classification. Results will provide guiding information that 
can help shape solutions for health care needs for the Haudenosaunee in NYS.
METHODS
Detailed methods for generating the analytic mortality files are described elsewhere (Espey 
et al., 2014b). An abbreviated description follows.
Data sources
Population estimates.—We used county-level population estimates produced by the U.S. 
Census Bureau as denominators in the rate calculations. To manage multiple race/ethnicity 
data collected since 2000, we used the National Center for Health Statistics (NCHS)/Census 
Bureau method of bridging race/ethnicity categories into single-race/ethnicity (Ingram et al., 
2003). The NCI made further refinements regarding race/ethnicity, county geographic codes, 
and adjustments for population shifts because of Hurricanes Katrina and Rita in 2005, and 
provided public access to these estimates at the Surveillance, Epidemiology, and End Results 
(SEER) website (NCI SEER, n.d.).
During preliminary analyses, we discovered that the updated bridged intercensal populations 
estimates significantly overestimated AI/AN persons of Hispanic origin (Edwards et al., 
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2013). Therefore, to avoid underestimating mortality in AI/AN populations, we limited 
analyses to non-Hispanic AI/AN persons. Non-Hispanic white was chosen as the most 
homogeneous referent group. For conciseness, the term “non-Hispanic” is henceforth 
omitted when discussing both groups.
Death records.—Each state compiles death certificate data and sends them to the NCHS, 
where they are edited for consistency. The NCHS makes this information available to 
researchers as part of the National Vital Statistics System (NVSS), and includes underlying 
and multiple cause of death fields, state of residence, age, sex, race, and ethnicity (National 
Center for Health Statistics, n.d.). NCHS and the Census Bureau use the same bridging 
algorithm to assign a single race to decedents with multiple races reported on the death 
certificate (National Center for Health Statistics, 2004).
The IHS patient registration database was linked to the National Death Index (NDI) to 
identify IHS decedents who had received health care in IHS or tribal facilities and were 
misclassified as non-AI/AN (Espey et al., 2014b). Following this linkage, IHS records for 
persons identified as deceased were then linked to 1990 to 2009 annual NVSS mortality files 
as an additional indicator of AI/AN ancestry. These files were combined with corresponding 
annual bridged race intercensal population estimates to create an analytic file, the AI/AN 
Mortality Database (AMD), in SEER*Stat software version 8.0.4 (Surveillance Research 
Program, n.d.). Race for AI/AN deaths is assigned as reported elsewhere (Espey et al., 
2014b). In short, the AMD combines race classification by NCHS on the basis of the death 
certificate and information derived from data linkages between the IHS patient registration 
database and the National Death Index.
For the years 1990–1998, the underlying cause of death was coded according to the 
International Classification of Diseases, Ninth Revision (ICD-9) (World Health 
Organization, 1980). For 1999–2009, the International Classification of Diseases, 10th 
Revision (ICD-10) was used (World Health Organization, 1999). Trend analyses spanning 
ICD-9 and ICD-10 reporting years took into account comparability of cause of death recodes 
between the two revisions (Anderson, Minino, Hoyert, & Rosenberg, 2001). To present the 
leading cause of death in rank order, as established by death counts, we used the method 
developed by NCHS based on the recode for 113 selected causes of death (Anderson et al., 
2001; Heron, 2012).
Geographic Coverage.—The analyses in this article are restricted to IHS Contract 
Health Service Delivery Area (CHSDA) counties, which follow county boundaries and are 
established by IHS for each federally recognized tribe. The CHSDA consists of counties that 
include all or part of a reservation, and any county or counties that have a common boundary 
with the reservation (Indian Health Service, 2016). Linkage studies have indicated less 
misclassification of race/ethnicity for AI/AN persons in these counties (Jim et al., 2014).
The analyses were completed for AI/AN and white persons in the Haudenosaunee Nations, 
East region, and the United States. The Haudenosaunee Nations are situated in nine NYS 
counties: Allegany, Cattaraugus, Chautauqua, Erie, Franklin, Genesee, Madison, Niagara, 
and Onondaga. Only counties that touched one of the Haudenosaunee Nations were included 
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in the analyses (Figure 1). The East region consists of Alabama, Arkansas, Connecticut, 
Delaware, Florida, Georgia, Kentucky, Louisiana, Maine, Maryland, Massachusetts, 
Mississippi, Missouri, New Hampshire, New Jersey, New York, North Carolina, Ohio, 
Pennsylvania, Rhode Island, South Carolina, Tennessee, Vermont, Virginia, West Virginia, 
and Washington, D.C. Identical or similar regional analyses have been used for other health-
related publications focusing on AI/AN populations (Espey et al., 2014a; Denny & Taylor, 
1999; Espey, Paisano, & Cobb, 2005; Wiggins et al., 2008).
Statistical methods.: All rates, expressed per 100,000 population, were directly age-
adjusted, using SEER*Stat software (Surveillance Research Program, n.d.), to the 2000 U.S. 
standard population and using 11 age groups (<1 year, 1–4 years, 5–14 years, 15–24 years, 
25–34 years, 35–44 years, 45–54 years, 55–64 years, 65–74 years, 75–84 years, and ≥ 85 
years) in accordance with a 1998 Department of Health and Human Services 
recommendation (Anderson, 1998a; Anderson, 1998b). Readers should avoid comparison of 
these data with published death rates adjusted using a different standard population.
Using the age-adjusted, all-cause death rates, standardized rate ratios (RRs) were calculated 
for AI/AN using white rates for comparison. Ninety-five percent confidence intervals (CI) 
for age-adjusted rates and standardized RRs were calculated based on methods described by 
Tiwari, Clegg, & Zou (2006) using SEER*Stat and were rounded to two decimal places.
We conducted trend analyses and comparability tests for age-standardized death rates using 
Joinpoint software, version 4.0.3 (Joinpoint Regression Program, 2017). We calculated 
annual percent change (APC) for each of the trend segments and average annual percent 
change (AAPC) for 1990–2009 to quantify the average trend over this period. We conducted 
tests to assess pairwise differences between AI/ANs and whites to determine whether the 
trends lines were parallel or coincident (Kim, Fay, Feuer, & Midthune, 2000), then we tested 
the average annual percentage change for the two groups to determine whether they were 
statistically different. Statistical significance was set at P<.05.
RESULTS
All-cause death rates and leading causes of death for the Haudenosaunee Nations, East, and 
United States comparing AI/AN with white persons in CHSDA counties are presented in 
Table 1. In subsequent results as well as in the discussion, “death rates” refers to analyses 
restricted to CHSDA counties only and for conciseness, the term “Haudenosaunee” will be 
used when discussing “Haudenosaunee Nations AI/AN”. Comparisons of all-cause death 
rates in Haudenosaunee with those of whites in the Haudenosaunee Nations (RR=1.16) were 
greater than those in the East (RR=1.03) but not as high as those in the U.S. (RR=1.41).
Table 1 also ranks the leading causes of death for AI/AN compared to white persons by sex 
for the Haudenosaunee Nations, East, and United States for 1990–2009. The ten leading 
causes of death among the Haudenosaunee, in order, were heart disease, cancer, 
unintentional injury, diabetes, stroke, chronic liver disease, chronic lower respiratory 
disease, influenza and pneumonia, kidney disease, and septicemia. Rates for Haudenosaunee 
were significantly higher than whites for all causes (RR=1.16), heart disease (RR=1.12), 
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unintentional injury (RR=2.08), diabetes (RR=3.46), chronic liver disease (RR=4.06), 
kidney disease (RR = 3.31), and septicemia (RR=1.85); and significantly lower for cancer 
(RR=0.89). Rates for stroke, chronic lower respiratory disease, suicide, and influenza and 
pneumonia were similar for Haudenosaunee and whites in the Haudenosaunee Nations.
In men, all cause death rates in the Haudenosaunee Nations (1,184.1 per 100,000) were 
higher than those in the East (995.9) but not as high as those in the U.S. (1,390.9). The 
leading cause of death was heart disease for both AI/AN and white men, with rates that 
ranged from 283.0 in East AI/AN to 395.0 for Haudenosaunee. The next ten leading causes 
of death for Haudenosaunee men were cancer, unintentional injury, diabetes, chronic liver 
disease, stroke, chronic lower respiratory disease, influenza and pneumonia, suicide, kidney 
disease, and homicide. Rates for Haudenosaunee males were significantly higher than whites 
for all causes (RR=1.14), heart disease (RR=1.13), unintentional injury (RR=2.26), diabetes 
mellitus (RR=3.29), chronic liver disease (RR=3.77), kidney disease (RR=1.74) and 
homicide (RR=4.68); and significantly lower for cancer (RR=0.79). Rates for suicide, 
stroke, chronic lower respiratory disease, and influenza and pneumonia were similar for 
Haudenosaunee and whites in the Haudenosaunee Nations.
In women, all cause death rates in the Haudenosaunee Nations (827.9 per 100,000) were 
greater than those in the East (730.9) but not as high as those in the United States (970.8). 
For AI/AN and white populations, all-cause death rates were substantially lower for women 
than for men in the Haudenosaunee Nations, East, and United States. The two leading causes 
of death for both AI/AN and white women were heart disease and cancer with heart disease 
death rates that ranged from 186.7 for U.S. whites to 248.5 for Haudenosaunee and cancer 
death rates that ranged from 139.5 for East AI/AN to 180.2 for U.S. AI/AN. The remaining 
leading causes of death for Haudenosaunee women are diabetes mellitus, stroke, 
unintentional injury, chronic lower respiratory disease, chronic liver disease, septicemia, 
influenza and pneumonia, and kidney disease. Rates for Haudenosaunee women were 
significantly higher than whites for all causes (RR=1.17), heart disease (RR=1.14), 
unintentional injury (RR=1.87), diabetes mellitus (RR=3.58), chronic liver disease 
(RR=4.47), kidney disease (RR=1.94), and septicemia (RR=2.30). Rates for cancer, stroke, 
chronic lower respiratory disease, and influenza and pneumonia were similar for 
Haudenosaunee and whites in the Haudenosaunee Nations.
Cancer death rates and leading cancer causes of death for the Haudenosaunee Nations, East, 
and U.S. comparing AI/AN with white persons by sex for 1990–2009 are presented in Table 
2. The six leading causes of cancer death among the Haudenosaunee were lung and 
bronchus (lung), colon and rectum (colorectal), liver and intrahepatic bile duct (liver), 
pancreas, kidney and renal pelvis (kidney), and stomach cancer. The Haudenosaunee all 
malignant cancers death rates was 180.8, which was higher than the East AI/AN death rates 
(161.5) but not as high as those for U.S. AI/AN (205.5). Rates for Haudenosaunee were 
significantly higher than whites for liver cancer (RR=2.58) and significantly lower for all 
malignant cancers (RR=0.89). The rates for lung, colorectal, pancreas, stomach and kidney 
cancer were similar for Haudenosaunee and whites in the Haudenosaunee Nations. 
Comparisons of liver cancer mortality in AI/AN with white populations were greatest in the 
Haudenosaunee Nations (RR=2.58) than those in the East region (RR=1.57) and the United 
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States (RR=2.40). Very large differences in liver cancer mortality were observed with higher 
rates among Haudenosaunee men (RR=2.69) and Haudenosaunee women (RR=2.84 – data 
not shown) when compared to whites.
In men, the all malignant cancers death rates range from 196.2 for East AI/AN to 251.6 for 
Haudenosaunee Nations whites. For all AI/AN males, the leading cancer causes of death are 
lung, colorectal, prostate, and liver. With the exception of lung cancer, Haudenosaunee men 
have higher cancer death rates for the leading cancer causes of death than the East AI/AN 
men. Rates for Haudenosaunee males were significantly higher than whites for liver cancer 
(RR=2.69); and significantly lower for all malignant cancers (RR=0.79) and lung cancer 
(RR=0.67). Rates for colorectal and prostate cancer were similar for Haudenosaunee and 
whites in the Haudenosaunee Nations.
In women, the all malignant cancers death rates range from 139.5 for East AI/AN to 180.2 
U.S. AI/AN. Haudenosaunee cancer mortality rates in women were 169.3 compared to 139.5 
for the East AI/AN. The Haudenosaunee reflected rates that were lower than those of whites, 
but this new data showed all malignant cancer death rates for Haudenosaunee women to be 
higher than those reported for the East AI/AN. For females in the Haudenosaunee Nations, 
the leading cancer causes of death were lung, colorectal, breast, and pancreatic cancer. With 
the exception of pancreatic cancer, Haudenosaunee women had higher cancer death rates for 
the leading cancer causes of death than the East AI/AN women. Rates for Haudenosaunee 
females were significantly lower than whites for breast cancer (RR=0.61). Rates for all 
malignant cancers, lung, colorectal and pancreatic cancer were similar for Haudenosaunee 
and whites in the Haudenosaunee Nations.
Death rates for all causes by age for AI/AN compared to whites for 1990–2009 are shown in 
Table 3. When examined by age, disparities in all-cause mortality were most evident in 
younger age groups, particularly ages 25 to 44 years. This pattern was apparent for the 
Haudenosaunee Nations, East, and United States. It was particularly prominent in the United 
States, where all-cause death rates in this age group for AI/AN were 2.6 times higher than 
that for whites, and the Haudenosaunee Nations, where all-cause death rates for 
Haudenosaunee were 1.9 times higher than that for whites. The disparities in all-cause 
mortality were higher in the Haudenosaunee Nations than in the East and were statistically 
significantly different for all age groups.
Figure 2 summarizes trends in all-cause mortality in CHSDA counties from 1990–2009 for 
Haudenosaunee, East AI/AN, U.S. AI/AN, and U.S. whites by sex. All-cause death rates for 
Haudenosaunee males declined 2.2% per year, whereas for East AI/AN males death rates 
declined 1.6% per year. Nationally, all-cause death rates remained stable for AI/AN males, 
whereas for white males, death rates declined 1.3% per year. Haudenosaunee females and 
East AI/AN females remained stable. Nationally, all-cause death rates for AI/AN females 
significantly increased 0.5% per year, whereas white female death rates were stable.
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DISCUSSION
Haudenosaunee all-cause death rates were substantially greater than those for East AI/AN 
but not as great as those for U.S. AI/AN. The most prominent disparities for all-cause death 
rates of Haudenosaunee are concentrated in the younger age groups. The significant 
decrease in all-cause death rates over the past two decades for Haudenosaunee males is 
declining at a greater percentage per year than East AI/AN, U.S. AI/AN and U.S. whites. 
Unfortunately, this decrease was not observed for Haudenosaunee females with all-cause 
death rates appearing to be stable over the past two decades. Lastly, the leading specific 
cause of death and age at death disparities indicates potential areas of intervention that can 
improve mortality among the Haudenosaunee.
Health disparities
Among the Haudenosaunee of NYS, the six leading causes of death compared to whites for 
both males and females combined between 1990 and 2009 were heart disease, cancer, 
unintentional injury, diabetes, stroke, and liver disease. Statistically significant differences 
were found between Haudenosaunee and whites for deaths related to unintentional injury, 
diabetes, and chronic liver disease (see Table 1). Although cancer was the second leading 
cause of death for both Haudenosaunee and whites, the Haudenosaunee had a lower cancer 
death rate than whites.
Cancer
Deaths related to all malignant cancers were higher among the Haudenosaunee than the IHS 
East region as a whole. After IHS linkage, death rates for Haudenosaunee men and women 
were higher than the IHS East region. However, these numbers were lower than all AI/ANs 
combined and whites which also coincided with previous findings (Mahoney et al., 2009; 
Mahoney, Michalek, Cummings, Hanley, & Snyder, 1989).
The top two leading cancers that caused death among the Haudenosaunee were lung and 
colorectal, with death rates nearly equivalent to those of whites. These new results were 
comparable to previous studies listing lung cancer and colon cancer as the leading causes of 
mortality for tribally enrolled men of one tribe of the Haudenosaunee, followed by lung, 
cervix, and breast cancer for enrolled women of the same Nation (Mahoney et al., 1989).
This analysis shares new concerns which were difficult to assess in a previous study of one 
Haudenosaunee Nation based on a limited number of cases (Mahoney et al., 2009).
First, liver disease and liver cancer is of significant concern in these new findings. Chronic 
liver disease was classified as the fifth leading cause of death in AI/ANs, with alcoholic liver 
disease, Hepatitis C Virus (HCV) infection and non-alcoholic fatty liver disease as the most 
common contributors (Suryaprasad et al., 2014). Non-alcoholic fatty liver disease or NASH, 
sometimes referred to as diabetes hepatitis, is an increasingly recognized condition that may 
progress to end-stage liver disease and cancer (Batman & Scheuer, 1985; Nagore & Scheuer, 
1988; Picardi & D’Avola, 2006). Obesity, type 2 diabetes, and hyperlipidemia are also 
coexisting conditions frequently associated with this disease (Suryaprasad et al., 2014; Than 
& Newsome, 2015; Aleksandrova, Stelmach-Mardas, & Schlesinger, 2016). Further, there 
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are data that suggest that steatosis with other liver disease, such as the HCV infection, could 
increase the risk of liver disease (Angulo, 2002).
Diabetes
Type 2 diabetes is often related to obesity and both often co-occur with other conditions and 
chronic diseases (Bril & Cusi, 2017; Rice et al., 2016; Vigneri, P., Frasca, Sciacca, Pandini, 
& Vigneri, R., 2009). These include fatty liver disease and certain types of cancer. Both 
chronic liver disease and liver cancer were concerns for both males and females of the 
Haudenosaunee compared to whites. Regionally, diabetes mortality for the Haudenosaunee 
nearly mirrored that found in the East region and among other AI/AN populations in NYS 
(data not shown) (Cho et al., 2014). However, mirroring nationwide findings, 
Haudenosaunee men and women die nearly 3.5 times more than whites from diabetes.
In regards to sex, diabetes rates in Haudenosaunee men were higher than those reported for 
East AI/AN, and closely mirrored rates for US AI/AN men. Mortality associated with 
diabetes for Haudenosaunee women was slightly lower than previous statistics shown for all 
AI/AN women in the East. These findings are similar to recent national data that indicated 
that age-adjusted diabetes prevalence rates among AI/AN persons were at least twice those 
of whites or the total U.S. population and ranked as the fourth leading cause of death for 
AI/AN persons (Cho et al., 2014).
LIMITATIONS
These results have several limitations. First, although linkage with the IHS patient 
registration database improves the classification of race for many AI/AN decedents, the 
issue is not completely resolved. AI/AN who are not members of federally recognized tribes 
are not eligible for IHS services and are therefore not represented in the IHS patient 
registration database. Additionally, some eligible decedents may have never used IHS 
services and were therefore not included in the IHS patient registration database. Second, the 
findings from CHSDA counties do not represent all AI/AN populations in the US or the East 
region, which includes only 18.2% of the total AI/AN population (Espey et al., 2014b). 
Furthermore, the analyses based on CHSDA designation exclude many AI/AN decedents in 
urban areas that are not part of a CHSDA county. AI/AN residents of urban areas differ from 
other AI/AN persons in poverty level, health care access, and other factors that may 
influence mortality trends (Jacobs-Wingo et al., 2016; Urban Indian Health Institute, 2008). 
Third, federally recognized tribes vary substantially in the proportion of native ancestry 
required for tribal membership and therefore for eligibility for IHS services. Whether or how 
this discrepancy in tribal membership requirements may influence some of our findings is 
unclear, although our findings are consistent with prior reports. Fourth, to capture enrolled 
and non-enrolled Haudenosaunee, analyses were restricted to the nine counties that comprise 
most of the Haudenosaunee Nations. The nine county restriction may have excluded 
Haudenosaunee that that do not live in these counties and included AI/ANs that belong to 
other tribes. Finally, although the exclusion of Hispanic AI/AN persons from the analyses 
reduces the overall US AI/AN deaths by less than 5%, it may disproportionately exclude 
some tribal members. For instance, tribal members in states along the US-Mexico border 
Haring et al. Page 10
Cancer Health Disparities. Author manuscript; available in PMC 2019 November 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
and possibly elsewhere who have Hispanic surnames and may be coded as Hispanic on the 
death certificate.
FUTURE RESEARCH
More research is needed to investigate what is causing the high mortality of liver disease and 
associated cancers affecting the Haudenosaunee. The relationship between mortality and 
obesity has been further supported in previous research from a member tribe of the 
Haudenosaunee. The research showed that, during a 30-year study period, 8.3 percent of 
years of potential life loss were due to digestive disorders that may be related to obesity and 
dietary practices (Mahoney et al. 1989). Further, in another tribe of the Haudenosaunee, six 
cardiovascular disease risk factors were evaluated. Of 95 school children, 55 represented 39 
interrelated families. Seventy-two percent of the family histories included diabetes mellitus 
and 42% of the children’s physical examinations revealed obesity (weight/height greater 
than 90th percentile) (Botash et al., 1992).
Future investigation is needed to discover if variables causing liver disease differ among the 
Haudenosaunee. These include specific variances between fatty liver disease, HCV, and the 
role of both alcoholic and non-alcoholic cirrhosis. Potential co-occurring conditions of 
concern related to liver disease and liver cancer are common among the Haudenosaunee and 
may be additive or synergistic in the development of disease. Hepatitis C infection rates 
should be evaluated. Otherwise, the stereotype of assuming the problems are all related to 
alcoholism might delay a more complete understanding of the health risks within this 
population. The impact of historical trauma, inducing adverse childhood experiences, among 
AI/ANs is just now being evaluated for its relationship to cancer (Brown et al., 2010; 
Shonkoff et al., 2009).
This is an initial paper and comparisons to ethnically and racially diverse populations that 
may be facing similar social determinants of health in the same geographic regions should 
be explored. Recent updated cancer incidence and mortality evaluations have clearly 
identified the importance of regional differences across AI/AN populations (Espey et al., 
2014a; Plescia, Henley, Pate, Underwood, & Rhodes, 2014). Disparities in cancer and other 
diseases are due to inequalities in socioeconomic status, sexual orientation, gender, disability 
status, geographic location, discriminatory practices, or some combination of factors 
(Brennan Ramirez, Baker, & Metzler, 2008; Krieger, Emmons, & Williams, 2009). Further, 
future studies could also include the review of other Haudenosaunee populations outside of 
NYS (i.e., Haudenosaunee located in Canada, Wisconsin, and Oklahoma).
For the Haudenosaunee and other AI/AN populations, chronic diseases, such as diabetes, 
heart disease and cancer, are now the norm (Cobb et al., 2014; Acton et al., 2002; Burrows, 
Geiss, Engelgau, & Acton, 2000; Go et al., 2013). There was a time when infectious 
diseases were the major health focus. Cancer was previously reported for whites and blacks 
only in the SEER Cancer Statistics Review. Now we know that all segments of the 
population, large and small, should have data that will guide resources and appropriate 
interventions in reducing cancer (Wallerstein & Duran, 2010). The definitions of population 
data are also very important, as shown here, so that the limitations can be understood and 
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data of higher quality can be collected going forward. Understanding factors affecting small 
population groups is crucial to overcoming disparities and will likely require new research 
designs with community-based participatory research as the guiding principle (Srinivasan et 
al., 2015). The community should be heard and their feedback incorporated into the way in 
which questions are asked and data used to develop culturally appropriate interventions 
(Cochran et al., 2008).
Overall, these new findings provide a crucial framework for tribal health centers, AI/AN 
urban centers, and those who work with the Haudenosaunee in NYS. These new data 
identify health disparity rates higher for the Haudenosaunee than previously published or in 
comparison to aggregate data for all Native Nations in the IHS East region. There should be 
a realization of cultural and traditional views of the Haudenosaunee and understanding of 
what is important to future generations, including the integration or enhancement of 
interventions and prevention programs. Such programs could also include the philosophies 
and traditional viewpoints of the people of the confederacy wrapped in a framework of 
resiliency and courage. Lastly, it is also important to be cognizant of historical factors 
related to environmental shifts, and generational stress, and how these may contribute to 
current health disparities (Brown et al., 2010; Shonkoff et al., 2009; Warne, 2005; Anda, 
Butchart, Felitti, & Brown, 2010; Felitti et al., 1998; Mehta et al., 2013).
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Figure 1. 
Haudenosaunee – Iroquois Confederacy
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Figure 2. 
Annual age-adjusted all-cause death rates and Joinpoint trend lines for males and females: 
CHSDA counties, US, 1990–2009
Note. AI/AN = American Indian/Alaska Native; CHSDA: Contract Health Service Delivery 
Area. Analyses are limited to persons of non-Hispanic origin. AI/AN race is reported from 
death certificates or through linkage with the IHS patient registration database. * α = 0.05.
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